CurifyLabs, an expert in 3D printing for compounded medications, which many know as the owner of 3D printing hardware IP from Mehta Heino Industries Oy , has released its next-generation software platform, CurifyLabs Create.
CurifyLabs Create aims to give pharmacists unprecedented flexibility to design and adapt formulations on demand.
Addressing the challenges of compounding
Compounding is the preparation of customized medicines for patients whose needs cannot be met by mass-produced drugs. It has long relied on manual, time-intensive processes with inherent risks.
To overcome this challenge, CurifyLabs’s Compounding System Solution integrates advanced software, GMP-grade excipient bases, and 3D printing technology.
“With our latest software release, we’re making compounding faster, more precise, and more adaptable than ever before,” said Charlotta Topelius, CurifyLabs CEO and Founder. “CurifyLabs Create empowers pharmacists to personalize therapies at the point of care, while our expanded excipient bases enable a wide range of patient-friendly dosage forms.”
Formulations and workflow
Already approved by more than 100 pharmacists who can formulate directly from pure APIs or crushed tablets, the software platform expands CURABLEND excipient bases. It supports multiple dosage forms, including tablets, liquids, films, suppositories, troches, and more.
Additionally, it ensures integrated quality and compliance thanks to built-in features aligned with FDA and GMP standards, including electronic records, audit trails, and validated processes.
Developed by pharmacists for pharmacists, CurifyLabs’ platform is up to four times faster than manual compounding. It also embeds robust quality safeguards to reduce risk and improve efficiency. By automating one of healthcare’s most time-consuming tasks, the solution not only alleviates clinical workloads but also enables patients to access safer, faster, and more personalized care.
“The demand for personalized compounding is accelerating, fueled by advances in pharmacogenomics and the need for tailored dosing—especially for children, seniors, and patients with complex conditions,” added Topelius. “With our enhanced software, working hand-in-hand with our first-of-its-kind 3D printing technology, we’re not just improving compounding—we’re redefining it for the future of healthcare.”
Make sure to follow us on our social networks and subscribe to our weekly newsletter: Facebook, Twitter, LinkedIn & Instagram ! If you want to be featured in the next issue of our digital magazine or if you hear a story that needs to be heard, make sure you send it to contact@3dadept.com
THE 3D ADEPT WEEKLY NEWSLETTER
The industry moves fast. Stay ahead.
Every week, the latest additive manufacturing news, in-depth features and real-world applications, straight to your inbox. Plus, be the first to know when a new issue of 3D ADEPT Mag is out.
Free · One email a week · Unsubscribe anytime
Clicking loads our email provider’s sign-up form, including its analytics and Google’s anti-bot protection. You’re only subscribed if you complete the sign-up. Read our privacy policy.